Lipid News

The promise of unknown unknowns

John  Browse
By John Browse
Feb. 1, 2015

“There are also unknown unknowns — the ones we don’t know we don’t know. And if one looks throughout the history of our country and other free countries, it is the latter category that tend to be the difficult ones.” — Donald Rumsfeld

 

For soldiers and politicians, it is indeed the unknown unknowns that are difficult. However, as researchers, we can rejoice that, despite the difficulty, these are what make our chosen pursuit worthwhile.

Two essential fatty acids derived from plants are linoleic (18:2) and alpha-linolenic (18:3) acids. These dietary fatty acids are precursors of the omega-6 and omega-3 fatty acids popularized in the press. In addition to their importance for human health, these lipids also compromise oxidative stability of vegetable oils, and removing them results in the production of undesirable (and now banned) trans fats. Given the importance of these lipids, their synthesis in plants has gained considerable attention.

In oil-accumulating cells of plant seeds, linoleic and alpha-linolenic acids (referred to here on out as 18:2 and 18:3, respectively) are generated by the desaturation of oleic acid (18:1) catalyzed by fatty acid desaturase, or FAD, enzymes FAD2 and FAD3. For FAD2 and FAD3 to work, oleic acid must be incorporated into the membrane lipid phosphatidylcholine. How 18:1 is incorporated into phosphatidylcholine has been debated.

In earlier models, 18:1 was known to be incorporated into phosphatidylcholine by one of two routes: direct incorporation from 18:1-CoA catalyzed by acyl-CoA:lyso-phosphatidylcholine acyltransferase, known as LPCAT for short, or incorporation into diacylglycerol followed by conversion into phosphatidylcholine by CDP-choline:diacylglycerol cholinephosphotransferase, or CPT. It also has been proposed that reversibility of the CPT reaction would provide one mechanism for the production of polyunsaturated diacylglycerol for the synthesis of triacylglycerols containing 18:2 and 18:3.

During our earlier studies, we isolated a mutant of the model plant Arabidopsis with increased total levels of 18:1 and reduced total levels 18:2 and 18:3 in its seed oil. This mutant, rod1 (short for reduced oleate desaturation 1), had substantially reduced levels of 18:2 and 18:3 in both triacylglycerol and the immediate precursor diacylglycerol relative to wild-type Arabidopsis.

The known reaction between phosphatidylcholine and ceramide (top) provided the clue to identify a novel reaction in lipid synthesis (bottom) catalyzed by phosphatidylcholine:diacylglycerol cholinephosphotransferase.

Surprisingly, however, phosphatidylcholine in the mutants contained increased 18:2 and 18:3. These data suggested to us that the rod1 mutation reduces transfer of 18:1 into phosphatidylcholine for desaturation but not the desaturation reaction itself. The known unknowns, lyso-PC acyltransferase and CPT, were eliminated from consideration by 14C-glycerol radiolabeling experiments and by sequencing the two CPT genes from rod1 and wild-type plants.

So what is ROD1? When the Arabidopsis genome sequence was completed in 2000, the puzzle of ROD1’s identity seemed to become a manageable task of identifying the gene locus by map-based cloning. However, when we completed this task and identified ROD1 as At3g15820, the encoded protein was annotated as a phosphatidic acid phosphatase-related protein. This made no sense in the context of our knowledge of the pathways of triacylglycerol synthesis or the fatty acid composition of rod1 seeds. Furthermore, assays of recombinant ROD1 protein found no detectable phosphatidic acid phosphatase activity.

Time for a Hail Mary pass? The geneticist’s equivalent of this desperate football strategy is a position-specific iterative basic local alignment search tool, or PSI-BLAST, search of protein databases. As in football, this approach most likely will get you in a mess, but there is always the chance that it will produce a winning touchdown.

Far down in the fourth iteration of our PSI-BLAST search (at entry No. 67) was a weak hit to a mammalian phosphatidylcholine:ceramide cholinephosphotransferase. This enzyme catalyzes transfer of the phosphocholine headgroup from phosphatidylcholine to ceramide, generating sphingomyelin and diacylglycerol.

Plants do not contain sphingomyelin, but the structure of ceramide is analogous in some respects to that of diacylglycerol, suggesting to us that ROD1 might catalyze the transfer of phosphocholine from 18:2/18:3-containing phosphatidylcholine to 18:1-containing diacylglycerol (see figure).

Indeed, assays of recombinant ROD1 confirmed this activity, revealing our discovery of a new enzyme of lipid metabolism, phosphatidylcholine:diacylglycerol cholinephosphotransferase. Called PDCT for short, this enzyme is required for efficient synthesis of 18:2 and 18:3, as well as some other fatty acids, during triacylglycerol accumulation in seeds. ROD1 also is expressed in vegetative tissues of plants.

Although the rod1 mutation does not result in substantial changes in root or leaf fatty-acid composition, it is possible that PDCT has a role in lipid homeostasis or remodeling of membrane lipids in response to temperature changes or other environmental perturbations.

ROD1 homologues are present in many plants, but no readily identifiable homologues are present in animals; however, the family of human proteins related to sphingomyelin synthase includes eight proteins of unknown function. Thus, it remains possible that PDCT will be found to play a role in lipid metabolism in animals as well.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
John  Browse
John Browse

John Browse  is the Charlotte Y. Martin and Regents' professor at the Institute of Biological Chemistry at Washington State University.

Related articles

From the journals: February 2019
Gelareh (Abulwerdi) Vinueza, Kerri Beth Boggs & Sasha Mushegian
Insights from recent plant studies
Changcheng Xu & John Shanklin
From the journals: JLR
Joseph Heath

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

National Academies propose initiative to sequence all RNA molecules
News

National Academies propose initiative to sequence all RNA molecules

April 19, 2024

Unlocking the epitranscriptome could transform health, medicine, agriculture, energy and national security.

From the journals: JLR
Journal News

From the journals: JLR

April 19, 2024

What can you do with artificial lipoproteins? A new key to angiogenesis. Flavonoids counteract oxidative stress. Read about recent papers on these topics.

Iron could be key to treating a global parasitic disease
Journal News

Iron could be key to treating a global parasitic disease

April 16, 2024

A study has found that leishmaniasis causes body-wide changes in iron balance, leading to red blood cell damage.

Environmental DNA is everywhere
News

Environmental DNA is everywhere

April 14, 2024

The ability to extract trace bits of DNA from soil, water, and even air is revolutionizing science. Are there pitfalls?

Early COVID-19 research is riddled with poor methods and low-quality results
News

Early COVID-19 research is riddled with poor methods and low-quality results

April 13, 2024

The pandemic worsened, but didn’t create, this problem for science.

From the journals: MCP
Journal News

From the journals: MCP

April 12, 2024

Three views of mass spec: analyzing secreted protein spectra, imaging mass spectrometry for clinical use and spectral libraries for MS data analysis. Read about these recent papers.